“…E. coli is incapable of producing glycosylated biopharmaceutical products, proteins that require complex assembly, or proteins with high numbers of disulfide bonds (Meyer and Schmidhalter, 2012). In addition, E. coli is not suitable for culturing conditions at high (Tao et al, 2005) and low pH (Wernick et al, 2016), and high temperatures (Hasunuma and Kondo, 2012;Bhalla et al, 2013). These conditions present advantages for contamination resistance (Tao et al, 2005;Wernick et al, 2016), reduced titration requirements, and consolidated bioprocesses (Hasunuma and Kondo, 2012;Bhalla et al, 2013;Olson et al, 2012) in which certain substrates can be broken down and consumed simultaneously.…”